EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 106 filers reported holding EPIZYME INC in Q3 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $18,858,000 | -15.1% | 1,779,094 | +8.5% | 0.68% | -13.3% |
Q2 2018 | $22,208,000 | +30.2% | 1,639,000 | +70.6% | 0.78% | +32.0% |
Q1 2018 | $17,057,000 | +34.6% | 960,970 | -4.8% | 0.59% | +18.4% |
Q4 2017 | $12,670,000 | -5.1% | 1,009,526 | +44.1% | 0.50% | -17.0% |
Q3 2017 | $13,345,000 | +33.4% | 700,526 | +5.8% | 0.60% | +12.5% |
Q2 2017 | $10,002,000 | -58.7% | 662,369 | -53.1% | 0.53% | -42.9% |
Q1 2017 | $24,243,000 | +25.1% | 1,413,596 | -11.7% | 0.94% | +17.3% |
Q4 2016 | $19,373,000 | +576.2% | 1,601,049 | +449.9% | 0.80% | +499.2% |
Q3 2016 | $2,865,000 | -55.0% | 291,179 | -53.2% | 0.13% | -46.8% |
Q2 2016 | $6,372,000 | – | 622,299 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |